实验性COVID-19疫苗安全，并产生免疫应答

NIAID赞助的1期试验性mRNA疫苗

中期结果显示，一种研究疫苗，即mRNA-1273，其设计目的是抵御SARS-CoV-2，即导致2019年冠状病毒病（COVID-19）的病毒，其耐受性普遍良好，并促进了健康成年人的中和抗体活性。

Experimental COVID-19 vaccine safe, generates immune response

https://www.sciencedaily.com/releases/2020/07/200714171338.htm

Lisa A. Jackson, Evan J. Anderson, Nadine G. Rouphael, Paul C. Roberts, Mamodikoe Makhene, Rhea N. Coler, Michele P. McCullough, James D. Chappell, Mark R. Denison, Laura J. Stevens, Andrea J. Pruijssers, Adrian McDermott, Britta Flach, Nicole A. Doria-Rose, Kizzmekia S. Corbett, Kaitlyn M. Morabito, Sijy O’Dell, Stephen D. Schmidt, Phillip A. Swanson, II, Marcelino Padilla, John R. Mascola, Kathleen M. Neuzil, Hamilton Bennett, Wellington Sun, Etza Peters, Mat Makowski, Jim Albert, Kaitlyn Cross, Wendy Buchanan, Rhonda Pikaart-Tautges, Julie E. Ledgerwood, Barney S. Graham, John H. Beigel, for the mRNA-1273 Study Group. An mRNA Vaccine against SARS-CoV-2 -- Preliminary Report. New England Journal of Medicine, July 14, 2020; DOI: 10.1056/NEJMoa2022483